Skip to main content
NSPR
NASDAQ Life Sciences

InspireMD's CGuard Prime 80cm Shows 100% Success in TCAR Trial, Zero Adverse Events

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$0.86
Mkt Cap
$36.319M
52W Low
$0.75
52W High
$2.932
52W Position info
15% above low
Off High info
71% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

NSPR is trading near its 52-week low of $0.75 (15% above the low).

Summary

InspireMD announced exceptionally strong 30-day results from its CGUARDIANS II clinical trial for the CGuard Prime 80 cm implant, showing 100% acute device success and zero major adverse events in TCAR procedures. These highly positive outcomes are crucial for the company, which has recently faced a 'going concern' warning, significant cash burn, and a product recall for a different CGuard Prime delivery system. The successful trial data could enable InspireMD to tap into the large U.S. TCAR market, estimated at 35,000 procedures annually, significantly expanding its addressable market. This potential market expansion is vital for the company's future revenue growth and financial stability. Investors will now focus on the anticipated FDA approval of the PMA supplement in the second half of 2026.

At the time of this announcement, NSPR was trading at $0.86 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $36.3M. The 52-week trading range was $0.75 to $2.93. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

NSPR - Latest Insights

NSPR
Nov 13, 2026, 8:12 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.6301
Real-time Price: $0.5056 info
Change: -$0.1245 (-20%) info
Market Cap: $27.556M info
NSPR
Nov 12, 2026, 5:24 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.6701
Real-time Price: $0.5056 info
Change: -$0.1645 (-25%) info
Market Cap: $27.556M info
NSPR
Nov 12, 2026, 4:45 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.650
Real-time Price: $0.5056 info
Change: -$0.1444 (-22%) info
Market Cap: $27.556M info
NSPR
Nov 12, 2026, 4:15 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.730
Real-time Price: $0.5056 info
Change: -$0.2244 (-31%) info
Market Cap: $27.556M info
NSPR
Nov 12, 2026, 4:03 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.9087
Real-time Price: $0.5056 info
Change: -$0.4031 (-44%) info
Market Cap: $27.556M info